Advertisement
Australia markets closed
  • ALL ORDS

    8,065.50
    +113.20 (+1.42%)
     
  • AUD/USD

    0.6613
    -0.0012 (-0.19%)
     
  • ASX 200

    7,793.30
    +110.90 (+1.44%)
     
  • OIL

    78.27
    -0.21 (-0.27%)
     
  • GOLD

    2,322.10
    -9.10 (-0.39%)
     
  • Bitcoin AUD

    96,117.69
    -610.91 (-0.63%)
     
  • CMC Crypto 200

    1,318.57
    -46.55 (-3.41%)
     

Vitalhub Full Year 2023 Earnings: EPS Misses Expectations

Vitalhub (TSE:VHI) Full Year 2023 Results

Key Financial Results

  • Revenue: CA$52.5m (up 31% from FY 2022).

  • Net income: CA$4.55m (up 275% from FY 2022).

  • Profit margin: 8.7% (up from 3.0% in FY 2022).

  • EPS: CA$0.10 (up from CA$0.029 in FY 2022).

revenue-and-expenses-breakdown
revenue-and-expenses-breakdown

All figures shown in the chart above are for the trailing 12 month (TTM) period

Vitalhub EPS Misses Expectations

Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 13%.

The primary driver behind last 12 months revenue was the United Kingdom (UK) segment contributing a total revenue of CA$34.3m (65% of total revenue). The largest operating expense was General & Administrative costs, amounting to CA$12.9m (34% of total expenses). Explore how VHI's revenue and expenses shape its earnings.

ADVERTISEMENT

Looking ahead, revenue is forecast to grow 12% p.a. on average during the next 2 years, compared to a 11% growth forecast for the Healthcare Services industry in North America.

Performance of the market in Canada.

The company's shares are down 1.2% from a week ago.

Risk Analysis

We don't want to rain on the parade too much, but we did also find 1 warning sign for Vitalhub that you need to be mindful of.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.